Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about clinical trials

During our virtual panel discussion on December 3rd, Prof. Rob Jones, spoke about the next steps that need to be taken in order for clinical trials to progress after the pandemic.

The speakers delved into the topic of the impact of Covid-19 on clinical trials in oncology during the discussion. You can watch the full discussion here.

“[For] Cancer Research UK overall, the average time from grant award letter to first patient in is two years, so even if we met halfway that would be a massive step forward.”

More feature videos...

Scroll to Top